PMV Pharmaceuticals GAAP EPS of -$0.41 misses by $0.02

2 days ago 1

PMV Pharmaceuticals press release (NASDAQ:PMVP): Q2 GAAP EPS of -$0.41 misses by $0.02.
Cash, cash equivalents, and marketable securities of $148.3 million as of June 30, 2025

Recommended For You